Infiltration of immune cells into CNS is one of the essential events in multiple sclerosis (MS) development. Adhesion molecules like the intercellular adhesion molecule 1 (ICAM-1) play critical role in this process. Therefore, the ICAM1 gene containing two important single-nucleotide polymorphisms (SNPs) belongs to candidate loci with possible involvement in MS susceptibility and/or severity. The objective of our case-control study was to analyze the association of two functional ICAM1 polymorphisms rs1799969 (or G241R) and rs5498 (or K469E) with susceptibility to MS and evaluate their influence on the age at disease onset, severity, neurological disability and progression rate. Two hundred forty-eight MS subjects (mean 39.2 years) and 208 age-matched controls (mean 35.6 years) were involved in the study. Genotyping of ICAM1 rs1799969 and rs5498 SNPs was performed by PCR-RFLP. Presence of the rs3135388 polymorphism tagging the major MS risk allele HLA-DRB1*15:01 allele was determined as well. Our analysis revealed no statistically significant association of ICAM1 polymorphisms with risk of MS development in the Slovak population. Stratification of study cohorts by gender, age at onset and presence of the HLA-DRB1*15:01 risk allele showed only moderate changes. Correlation of clinical findings as age at onset, Kurtzke Expanded Disability Status Scale, Multiple Sclerosis Severity Score and progression index with ICAM1 genotypes in MS patients revealed no significant association; however, patients with earlier onset of MS showed slightly higher frequencies of the homozygous G allele at rs5498 in comparison to other genotypes (P = 0.04), suggesting that GG carriers tend to induce MS at an earlier age.

1st Department of Neurology Faculty of Medicine Comenius University and University Hospital Bratislava Slovakia

2nd Department of Neurology Faculty of Medicine Comenius University and University Hospital Bratislava Slovakia

Clinic of Neurology Jessenius Faculty of Medicine in Martin and University Hospital Comenius University Martin Slovakia

Department of Clinical Biochemistry Jessenius Faculty of Medicine in Martin and University Hospital Comenius University Martin Slovakia

Institute of Immunology Faculty of Medicine Comenius University Odborarske nam 14 813 72 Bratislava Slovakia

Zobrazit více v PubMed

J Neuroimmunol. 2013 Feb 15;255(1-2):92-6 PubMed

Genes Immun. 2003 Oct;4(7):518-23 PubMed

Nature. 2011 Aug 10;476(7359):214-9 PubMed

Immunology. 1994 Mar;81(3):366-72 PubMed

Biochem Biophys Res Commun. 2014 Jun 13;448(4):372-8 PubMed

Ann Neurol. 1998 Jul;44(1):70-5 PubMed

Cell. 1987 Dec 4;51(5):813-9 PubMed

Clin Exp Rheumatol. 2000 Sep-Oct;18(5):553-8 PubMed

Hum Immunol. 2003 Mar;64(3):345-9 PubMed

Neurology. 2005 Apr 12;64(7):1144-51 PubMed

Folia Biol (Praha). 2015;61(1):8-13 PubMed

Genomics. 1994 Jun;21(3):473-7 PubMed

Am J Epidemiol. 2007 May 15;165(10):1097-109 PubMed

Tissue Antigens. 2008 Oct;72(4):401-3 PubMed

Nucleic Acids Res. 1988 Feb 11;16(3):1215 PubMed

Tissue Antigens. 2004 Oct;64(4):473-7 PubMed

Blood. 1998 Sep 1;92(5):1626-38 PubMed

Int J Mol Med. 2011 Oct;28(4):467-79 PubMed

Tissue Antigens. 2000 Jun;55(6):568-70 PubMed

Nat Genet. 2005 Oct;37(10):1108-12 PubMed

Eur J Immunogenet. 2000 Apr;27(2):73-6 PubMed

J Neurol. 2000 Sep;247(9):677-80 PubMed

J Clin Invest. 2012 Apr;122(4):1180-8 PubMed

Clin Chim Acta. 2009 Aug;406(1-2):27-30 PubMed

Nat Genet. 2013 Nov;45(11):1353-60 PubMed

Cell. 1989 Mar 10;56(5):839-47 PubMed

Autoimmun Rev. 2012 Jan;11(3):163-6 PubMed

Neurology. 1983 Nov;33(11):1444-52 PubMed

Mol Biol Rep. 2012 Dec;39(12):10723-9 PubMed

Mod Rheumatol. 2014 May;24(3):481-6 PubMed

Cell. 1989 Mar 10;56(5):849-53 PubMed

Cell. 1991 Jun 14;65(6):961-71 PubMed

J Clin Invest. 1989 Jun;83(6):2008-17 PubMed

J Virol. 1993 Jan;67(1):390-7 PubMed

Hum Immunol. 2008 Feb;69(2):71-8 PubMed

Ann Neurol. 2000 Feb;47(2):277-9 PubMed

Immunol Res. 1998;17(3):313-27 PubMed

J Neurol Sci. 2015 Feb 15;349(1-2):138-42 PubMed

Immunology. 1995 Nov;86(3):408-15 PubMed